Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000935836-26-000399
Filing Date
2026-08-13
Accepted
2026-08-13 14:27:09
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5153
  Complete submission text file 0000935836-26-000399.txt   6562
Mailing Address 467 CENTRAL PARK WEST NY NY 10025
Business Address
LYTTON LAURENCE W (Filed by) CIK: 0001105806 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Subject) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91159 | Film No.: 261272414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)